共 69 条
[1]
Bohan A(1975)Polymyositis and dermatomyositis N Engl J Med 292 344-347
[2]
Peter JB(2016)Selected aspects of the current management of myositis Ther Adv Musculoskelet Dis 8 136-144
[3]
Lilleker J(2020)Pitfalls in the diagnosis of myositis Best Pract Res Clin Rheumatol 34 101486-2003
[4]
Murphy S(2019)Microsporidial myositis in adult-onset immunodeficiency: case-based review Rheumatol Int 39 1995-226
[5]
Cooper R(2016)The diagnosis and treatment of antisynthetase syndrome Clin Pulm Med 23 218-232
[6]
Chinoy H(2014)Patients with non-Jo-1 anti-tRNA-synthetase autoantibodies have worse survival than Jo-1 positive patients Ann Rheum Dis 73 227-92
[7]
Lilleker JB(2020)239th ENMC International Workshop: classification of dermatomyositis, Amsterdam, the Netherlands, 14–16 December 2018 Neuromuscul Disord NMD 30 70-267
[8]
Sundaram TG(2009)Association of distinct clinical subsets with myositis-specific autoantibodies towards anti-155/140-kDa polypeptides, anti-140-kDa polypeptides, and anti-aminoacyl tRNA synthetases in Japanese patients with dermatomyositis: a single-centre, cross-sectional study Scand J Rheumatol 38 263-1981
[9]
Aggarwal A(2019)Clinical spectrum and therapeutics in Canadian patients with anti-melanoma differentiation-associated gene 5 (MDA5)-positive dermatomyositis: a case-based review Rheumatol Int 39 1971-47
[10]
Ganguly S(2018)Mortality in idiopathic inflammatory myopathy: results from a Swedish nationwide population-based cohort study Ann Rheum Dis 77 40-52